Mao et al38 discovered that miR‐181a‐5p interacts with fibroblast growth factor receptor 3 (FGFR3) to promote the progression of bladder cancer through the activation of the STAT3 pathway. This evidence concerns the gene STAT3 and urinary bladder carcinoma.